Skip to main content
$0.042 -0.001 (-2.33%)

High

$0.04

Low

$0.04

Trades

17

Turnover

$24,861

Volume

582,113
30 June 2023 at 3:56pm
If you were already registered, log in here.

Short Interest

ASIC data, 6 Dec 2024

% Shorted

0.21% 0.20
vs 0.01% prior report

Most Shorted Rank

374th
of 717 shorted ASX stocks

Peak Short

15.90%
Jul 2014

Days to Cover

0.8
at 50d avg vol
Subject
ACR Ann: Appendix 3Y Brooke

ACR Ann: Application for quotation of securities - ACR

ACR Ann: 4th FDA ANDA approval received - Dapsone Gel, 5%

ACR Ann: Appendix 3Y Dobinson

ACR Ann: Appendix 3Y Brumley

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ACR Ann: Appendix 3Y Oldham

ACR Ann: Appendix 3Y Brooke

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Notification of cessation of securities - ACR

ACR Ann: Appendix 3Y Buumley

ACR Ann: Appendix 3Y Dobinson

ACR Ann: Appendix 3Y Brumley

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Appendix 4D and Half Year Report

ACR Ann: Notification regarding unquoted securities - ACR

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Quarterly Activities / Appendix 4C Cashflow Report

ACR Ann: Gedeon Richter buyout Lenzetto Royalties for EUR4.1million

ACR Ann: Positive FDA Remote Regulatory Assessment

ACR Ann: Launch of prilocaine and lidocaine cream in United States

ACR Ann: Mutual Termination of Co-Development Agreement

ACR Ann: Appendix 3Y - Brooke

ACR Ann: Appendix 3Y - Dobinson

ACR Ann: Appendix 3Y - Brumley

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Appendix 3Y Dobinson

ACR Ann: Appendix 3Y Brooke

ACR Ann: Appendix 3Y Oldham

ACR Ann: Appendix 3Y Brumley

ACR Ann: Notification regarding unquoted securities - ACR

ACR Ann: Results of AGM

ACR Ann: Chairman and CEO address to AGM

ACR Ann: Final FY22 R&D Tax Incentive balance received (OSF)

ACR Ann: Appendix 3Y Geoff Brooke

ACR Ann: Appendix 3Y Ross Dobinson

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ACR Ann: R&D Tax Incentive receipt - Overseas Finding

ACR Ann: Notice of Annual General Meeting/Proxy Form

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Remaining balance of R&D Tax Incentive Rebate received

ACR Ann: R&D Tax Incentive Rebate received

ACR Ann: Notification of cessation of securities - ACR

ACR Ann: Appendix 3Y - Brumley

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Appendix 4G and Corporate Governance Statement

ACR Ann: Appendix 4E and FY22 Annual Report

ACR Ann: Acrux's sixth generic dossier accepted by FDA for review

If you were already registered, log in here.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL
S88
MAV
CX8
MTX $12m raise
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS